Back to mobile site

Fortrea buys Worldwide Clinical Trials early phase unit for $45M

October 19, 2026 4:05 PM EDT Send to a Friend
Fortrea (Nasdaq: FTRE) has completed its acquisition of the Early Phase Services division from Worldwide Clinical Trials in an all-cash ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login